1. Home
  2. RDHL vs MEHA Comparison

RDHL vs MEHA Comparison

Compare RDHL & MEHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

N/A

Current Price

$0.80

Market Cap

3.8M

Sector

Health Care

ML Signal

N/A

MEHA

Functional Brands Inc.

N/A

Current Price

$0.13

Market Cap

3.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RDHL
MEHA
Founded
2009
2020
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.5M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
RDHL
MEHA
Price
$0.80
$0.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.5K
2.0M
Earning Date
05-01-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$381.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$0.11
52 Week High
$3.31
$0.74

Technical Indicators

Market Signals
Indicator
RDHL
MEHA
Relative Strength Index (RSI) 41.73 41.50
Support Level $0.79 $0.13
Resistance Level $0.89 $0.23
Average True Range (ATR) 0.05 0.03
MACD 0.01 -0.00
Stochastic Oscillator 51.31 30.31

Price Performance

Historical Comparison
RDHL
MEHA

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About MEHA Functional Brands Inc.

Functional Brands Inc operates in the nutraceutical supplement industry. It is a manufacturer and distributor of supplements in categories such as pain, energy, prenatal, general health, bone and joint, gastro, immunity, cardiac, detox, brain and memory, sleep, prenatal and urinary. It is focus on end-consumers through different channels that include pharmacies, wholesalers, international distributors and direct-to-consumers sales. The Company has two reportable segments: 1) Kirkman, which sells a range of nutraceuticals, supplements and related products direct to consumers; 2) HT Naturals, which sells a range of hemp products. Key revenue is generated from Kirkman.

Share on Social Networks: